Get the Stockscreener App
7.30
1.39%
0.10
After Hours:
7.30
Journey Medical Corp stock is traded at $7.30, with a volume of 51,406.
It is up +1.39% in the last 24 hours and up +15.69% over the past month.
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
See More
Previous Close:
$7.20
Open:
$7.17
24h Volume:
51,406
Relative Volume:
0.40
Market Cap:
$126.26M
Revenue:
$56.13M
Net Income/Loss:
$-14.67M
P/E Ratio:
-9.8649
EPS:
-0.74
Net Cash Flow:
$-9.13M
1W Performance:
+1.11%
1M Performance:
+15.69%
6M Performance:
+99.45%
1Y Performance:
+27.40%
1-Day Range:
$7.115
$7.35
1-Week Range:
$6.83
$8.00
52-Week Range:
$3.535
$8.2487
Journey Medical Corp Stock (DERM) Company Profile
Name
Journey Medical Corp
Sector
Phone
480-434-6670
Address
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Compare DERM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
7.30 | 168.20M | 56.13M | -14.67M | -9.13M | -0.74 |
|
ZTS
Zoetis Inc
|
150.03 | 70.70B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.74 | 46.87B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.59 | 45.41B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.31 | 18.96B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
297.33 | 13.54B | 2.99B | 1.21B | 1.13B | 25.06 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-22-24 | Initiated | Rodman & Renshaw | Buy |
| Jun-28-24 | Resumed | ROTH MKM | Buy |
| Dec-07-21 | Initiated | B. Riley Securities | Buy |
Journey Medical Corp Stock (DERM) Latest News
YDAPP(ydapp) Project ReviewBreakout Setup Scanner - Newser
What makes Journey Medical Corporation stock price move sharplyWealth Building Stock Portfolio - Newser
What makes KINS stock price move sharplyFree Access to Community - Newser
What makes Ellington Financial Inc. stock price move sharplyWeekly Big Movers - Newser
What makes Star Fashion Culture Holdings Limited stock price move sharplyLow Risk Scalping Alerts - Newser
What makes Autonomix Medical Inc. stock price move sharplyTop Rated Trade Entries - Newser
Why LPL Financial Holdings Inc. stock attracts strong analyst attentionFree Financial Group - Newser
What makes ATMCU stock price move sharplyFree Real-Time Trading Opportunities - Newser
When DCOMP stock expected to show significant growthIs CCEP stock a good long term investment optionSteady Profit Stock Forecasts - Newser
How Journey Medical Corporation stock performs during market volatilityWealth Building Stock Portfolio - Newser
How AmpliTech Group Inc. stock performs during market volatilityFree Real-Time Stock Data - Newser
Why Outset Medical Inc. stock attracts strong analyst attentionProfit Focused Trade Alerts - Newser
How AirJoule Technologies Corporation stock performs during market volatilityTop Performing Stocks - Newser
Why Orthofix Medical Inc. stock attracts strong analyst attentionSmart Money Trade Setups - Newser
Journey Medical Expands Pharmacy Coverage for Emrosi - TipRanks
Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi?? - MarketScreener
Journey Medical’s rosacea treatment reaches 65% commercial coverage - Investing.com
Journey Medical announces expanded payer coverage for Emrosi - TipRanks
Journey Medical's Emrosi Coverage Jumps to 65% of U.S. Commercial Lives - MarketScreener
Journey Medical Corporation Reports Increase in Payer Coverage for Emrosi™ to 65% of Commercial Lives, Supporting Growing Prescription Demand - Quiver Quantitative
Journey Medical Corporation Announces Expanded Payer Coverage for Emrosi™ - Stock Titan
From Need to Reimbursed Technology: Lessons from an 11-Year Journey - Stanford Medicine
Tailforce Unleashes Ozzy: The World’s First AI Executive Assistant Doggo for Smarter Email, Scheduling, and Customer Support - Quantisnow
Journey Medical (NASDAQ:DERM) Rating Lowered to “Hold” at Wall Street Zen - Defense World
Cambridge Investment Research Advisors Inc. Boosts Holdings in Journey Medical Corporation (NASDAQ:DERM) - Defense World
Journey Medical Corporation(NasdaqCM: DERM) added to Russell 2000 Growth Index - MarketScreener
DERM SEC FilingsJourney Medical Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Journey Medical Corp Holds 2025 Annual Stockholders Meeting - TipRanks
Is Journey Medical Corp. overvalued or undervalued? - MarketsMojo
Journey Medical Joins Russell 2000 and 3000 Indices - TipRanks
Fortress Biotech shareholders approve board proposals at annual meeting - Investing.com
Journey Medical Corporation (NASDAQ:DERM) Short Interest Update - MarketBeat
Journey Medical (NASDAQ:DERM) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat
Wall Street Zen Downgrades Journey Medical (NASDAQ:DERM) to Hold - Defense World
Journey Medical Co. (NASDAQ:DERM) Receives Average Rating of "Buy" from Analysts - MarketBeat
Ping An Good Doctor Revamps Brand and Launches Annual Healthcare Service Brand - Yahoo Finance
Journey Medical (DERM) Highlights Emrosi on National TV | DERM S - GuruFocus
Journey Medical announces Emrosi featured on “The Balancing Act” - TipRanks
Birchtech Strengthens Water Treatment Commercialization Team with Strategic Leadership Appointments - The Manila Times
Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV - Yahoo Finance
44,568 Shares in Journey Medical Co. (NASDAQ:DERM) Acquired by Citadel Advisors LLC - Defense World
Citadel Advisors LLC Takes Position in Mingteng International Co. Inc. (NASDAQ:MTEN) - Defense World
Journey Medical stock soars to 52-week high of $8.25 By Investing.com - Investing.com South Africa
Journey Medical stock soars to 52-week high of $8.25 - Investing.com
Tang Capital Management LLC Buys Shares of 1,725,569 Journey Medical Co. (NASDAQ:DERM) - MarketBeat
Contrasting Amarantus BioScience (OTCMKTS:AMBS) and Journey Medical (NASDAQ:DERM) - Defense World
Q2 EPS Estimates for Journey Medical Reduced by Roth Capital - MarketBeat
Quipt Home Medical Corp: Navigating the Financial Waters - timothysykes.com
Journey Medical Q2 EPS Forecast Decreased by Roth Capital - Defense World
20,455 Shares in Journey Medical Co. (NASDAQ:DERM) Purchased by Dimensional Fund Advisors LP - Defense World
Journey Medical Corporation (NASDAQ:DERM) Q1 2025 Earnings Call Transcript - Insider Monkey
Journey Medical Corp Stock (DERM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.09%
3.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):